Catalyst Wire Dossier Catalyst Wire Dossier

Emselex

darifenacin hydrobromide · pharmaand GmbH
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Emselex, covering 2010-04-30 to 2025-09-15. Get the full timeline:

Most recent: EMA Authorised: Emselex (darifenacin hydrobromide) — pharmaand GmbH

See pricing